“Analysis of the degree of fibrosis in patients with steatotic liver disease associated with metabolic dysfunction (MASLD) using FibroScan®” (2026) Electronic Journal Collection Health, 26(1), p. e22602. doi:10.25248/reas.e22602.2026.